Regulation of aromatase P450 expression by puerarin in endometrial cell line RL95-2

Journal of Chinese Integrative Medicine

Volumn 6, Issue 10, 2008, Pages 1017-1023

  Li, Yan Wei ^a   Cai, Zai Long ^a   Shen, Wei ^a   Yang, Sheng Sheng ^b   Yu, Chao Qin ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Aromatase P450; Endometriosis; Puerarin

Indexed keywords

AROMATASE; CIS ACTING ELEMENT; COMPLEMENTARY DNA; DIMETHYL SULFOXIDE; GENOMIC DNA; LUCIFERASE; MESSENGER RNA; PROTEIN C FOS; PROTEIN C JUN; PUERARIN; TRANSCRIPTION FACTOR AP 1; AROMATASE INHIBITOR; ISOFLAVONE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; COMPUTER PROGRAM; CONTROLLED STUDY; DNA FLANKING REGION; DOWN REGULATION; ENDOMETRIOSIS; ENDOMETRIUM CARCINOMA; ENDOMETRIUM CELL; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOLECULAR CLONING; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; RESTRICTION SITE; STATISTICAL SIGNIFICANCE; TRANSCRIPTION REGULATION; CELL LINE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECTS; ENDOMETRIUM; ENZYMOLOGY; FEMALE; GENETICS; METABOLISM;

AROMATASE; AROMATASE INHIBITORS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ENDOMETRIUM; FEMALE; HUMANS; ISOFLAVONES; RNA, MESSENGER; TRANSCRIPTION FACTOR AP-1;

EID: 55049094548     PISSN: 16721977     EISSN: None     Source Type: Journal    
DOI: 10.3736/jcim20081006     Document Type: Article

References (28)

1. Bulun SE, Fang Z, Imir G, et al. Aromatase and endometriosis. Semin Repod Med. 2004; 22 (1): 45-50.
2. Bulun SE, Imir G, Utsunomiya H, et al. Aromatase in endometriosis and uterine leiomyomata. J Steroid Biochem Mol Biol. 2005; 95(1-5): 57-62.
3. Bulun SE, Lin Z, Imir G, et al. Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment. Pharmacol Rev. 2005; 57(3): 359-383.
4. Mousa NA, Bedaiwy MA, Casper RF. Aromatase inhibitors in the treatment of severe endometriosis. Obstet Gynecol. 2007; 109(6): 1421-1423.
5. arom (CYP19) activity by natural and synthetic flavonoid compounds in H295R human adrenocortical carcinoma cells. Toxicol Sci. 2004; 82 (1): 70-79.
6. Tsuchiya M, Miura T, Hanaoka T, et al. Effect of soy tsoflavones on endometriosis: interaction with estrogen receptor 2 gene polymorphism. Epidemiology. 2007; 18 (3): 402-408.
7. Rice S, Mason HD, Whitehead SA. Phytoestrogens and their low dose combinations inhibit mRNA expression and activity of aromatase in human granulosa-luteal cells. J Steroid Biochem Mol Biol. 2006; 101(4-5): 216-225.
8. Yeung DK, Leung SW, Xu YC, et al. Puerarin, an isoflavonoid derived from Radix puerariae, potentiates endothelium-independent relaxation via the cyclic AMP pathway in porcine coronary artery. Eur J Pharmacol. 2006; 552(1-3): 105-111.
9. Yan LP, Chan SW, Chan AS, et al. Puerarin decreases serum total cholesterol and enhances thoracic aorta endothelial nitric oxide synthase expression in diet-induced hypercholesterolemic rats. Life Sci. 2006; 79 (4): 324-330.
10. Zhang S, Ji G, Liu J. Reversal of chemical-induced liver fibrosis in Wistar rats by puerarin. J Nutr Biochem. 2006; 17(7): 485-491.
11. Xiong FL, Sun XH, Gan L, et al. Puerarin protects rat pancreatic islets from damage by hydrogen peroxide. Eur J Pharmacol. 2006; 529(1-3): 1-7.
12. +-induced neurotoxicity in PC12 cells mediated by inhibiting mitochondrial dysfunction and caspase-3-like activation. Neurosci Res. 2005; 53 (2): 183-188.
13. Xu ME, Xiao SZ, Sun YH, et al. The study of antimetabolic syndrome effect of puerarin in vitro. Life Sci. 2005; 77(25): 3183-3196.
14. Kazmierczak W, Skalba P, Dabkowska-Huc A. et al. Expression of aromatase and 5-alpha-reductase genes in endometrial adenocarcinoma. Pathol Res Pract. 2096; 202(11): 789-791.
15. Berstein L, Zimarina T, Kovalevskij A, et al. CYP19 gene expression and aromatase activity in endometrial cancer tissue: importance of the type of the disease. Neoplasma. 2005; 52(2): 115-118.
16. Huang JC, Ruan CH, Tang K, et al. Prunella stica inhibits the proliferation but not the prostaglandin production of ishikawa cells. Life Sci. 2006; 79 (5): 436-441.
17. Chen YP, Higgins JA, Gundersen-Rindal DE. Quantitation of a Glyptapanteles indiensis polydnavirus gene expressed in parasitized host, Lymantria dispar, by real-time quantitative RT-PCR. J Virol Methods. 2003; 114(2): 125-133.
18. Wolters M, Hahn A. Soy isoflavones - a therapy for menopausal symptoms? Wien Med Wochenschr. 2004; 154(13-44): 334-341.
19. Whitten PL, Patisaul HB, Young LJ. Neurobehavioral actions of coumestrol and related isoflavonoids in rodents. Neurotoxicol Teratol. 2002; 24(1): 47-54.
20. Overstreet DH, Keung WM, Rezvani AH, et al. Herbal remedies for alcoholism: promises and possible pitfalls. Alcohol Clin Exp Res. 2003; 27(2): 177-185.
21. Xu X, Zhang S, Zhang L, et al. The Neuroprotection of puerarin against cerebral ischemia is associated with the prevention of apoptosis in rats. Planta Med. 2005; 71(7): 585-591.
22. Fatemi HM, Al-Turki HA, Papanikolaou EG, et al. Successful treatment of an aggressive recurrent postmenopausal endometriosis with an aromatase inhibitor. Reprod Biomed Online. 2005; 11(4): 455-457.
23. Lephart ED, Setchell KD, Handa RJ, et al. Behavioral effects of endocrine-disrupting substances: phytoestrogens. ILAR J. 2004; 45(4): 443-454.
24. Myllymaki S, Haavisto T, Vainio M, et al. In vitro effects of diethylstilbestrol, genistein, 4-tert-butylphenol, and 4-tertoctylphenol on steroidogenic activity of isolated immature rat ovarian follicles. Toxicol Appl Pharmacol. 2005; 204(1): 69-80.
25. Ranney B. Etiology, prevention and inhibition of endometriosis. Clin Obstet Gynecol. 1980; 23(3): 875-882.
26. Noble LS, Simpson ER, Johns A, et al. Aromatase expression in endometriosis. J Clin Endocrinol Metab. 1996; 81(1): 174-179.
27. Liu Y, Teng CT. Identification of the estrogen sensitive marker in human endometrial carcinoma RL95-2 cells. Mol Cell Endocrinol. 1994; 101(1-2): 167-171.
28. Mao CP, Gu ZL. Puerarin reduces increased c-fos, c-jun, and type IV collagen expression caused by high glucose in glomerular mesangial cells. Acta Pharmacol Sin. 2005; 26(8): 982-986.